Transcutaneous Suboccipital Neurostimulation for the Treatment of Chronic Migraine
试验速览
- 阶段
- 4 期
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Monthly frequency of migraine days
研究概览
简要总结
This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.
详细描述
Chronic migraine is a disabling neurological condition affecting 0.5-2% of the population.
CM is difficult to treat and preventive treatment options are limited. Due to the inefficiency of available and the lack of new preventive anti-migraine drug, neurostimulation methods have raised great interest in recent years.
The ONSTIM study showed a reduction in headache frequency in 39% of patients treated with active ONS during 12 weeks, compared to no improvement in the "non-effectively" stimulated or medically treated groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •diagnosis of chronic migraine (ICHD III beta 1.3) with or without medication overuse
排除标准
- •other diseases
结局指标
主要结局
Monthly frequency of migraine days
时间窗: 2 months treatment
次要结局
- Monthly frequency of headache days(2 months)
- Monthly acute drug intake(2 months)
- Monthly frequency of total headache days(2 months)
- Cumulative monthly headache hours(2 months)
研究者
Jean Schoenen
Honorary Full Professor
University of Liege
